Sterns E E, Fletcher W A, Zee B
Department of Surgery, Queen's University, Kingston, Ontario, Canada.
Ann Surg. 1992 Nov;216(5):560-4. doi: 10.1097/00000658-199211000-00006.
Because postoperative radiation reduces chest wall metastasis after mastectomy, it is important to identify patients in whom it might develop. Pathologic and immunohistochemical features in 59 patients with chest wall metastasis were compared with characteristics in disease-free patients and patients with systemic metastases without chest wall metastasis. Immunohistochemical studies with human milk-fat globule (HMFG)-2 were not predictive, but a membrane reaction with HMFG-1 was associated with fewer systemic metastases and tumors, in which most of the cells reacted with the antibody had significantly decreased likelihood of chest wall metastasis. Antigenic concordance between the primary breast cancer and the chest wall metastasis was demonstrated. Neither tumor size nor axillary node metastasis predicted development of chest wall metastasis, but systemic metastases were less common when fewer than four nodes were involved, the primary tumor was well differentiated, and estrogen receptors were positive.
因为术后放疗可降低乳房切除术后胸壁转移的发生率,所以识别可能发生胸壁转移的患者很重要。将59例胸壁转移患者的病理和免疫组化特征与无病患者及有全身转移但无胸壁转移患者的特征进行了比较。人乳脂肪球(HMFG)-2免疫组化研究无预测价值,但HMFG-1的膜反应与较少的全身转移和肿瘤相关,其中大多数与抗体反应的细胞发生胸壁转移的可能性显著降低。原发性乳腺癌与胸壁转移之间存在抗原一致性。肿瘤大小和腋窝淋巴结转移均不能预测胸壁转移的发生,但当受累淋巴结少于4个、原发性肿瘤分化良好且雌激素受体阳性时,全身转移较少见。